Alyeska Investment Group’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,333
Closed -$325K 524
2022
Q4
$325K Buy
+3,333
New +$325K ﹤0.01% 384